Egile-bilaketaren emaitzak :: Library Catalog

1

Figure 4 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Argitaratua 2025
Beste egile batzuk:

Gogokoenen artean sartu

Gorde:
2

Figure 1 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Argitaratua 2025
Beste egile batzuk:

Gogokoenen artean sartu

Gorde:
3

Figure 2 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Argitaratua 2025
Beste egile batzuk:

Gogokoenen artean sartu

Gorde:
4

Figure 3 from In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Argitaratua 2025
Beste egile batzuk:

Gogokoenen artean sartu

Gorde:
5

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Argitaratua 2025
Beste egile batzuk: “...Alison M. Meynert (14956260)...”

Gogokoenen artean sartu

Gorde:
6

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Argitaratua 2025
Beste egile batzuk: “...Alison M. Meynert (14956260)...”

Gogokoenen artean sartu

Gorde:
7

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Argitaratua 2025
Beste egile batzuk: “...Alison M. Meynert (14956260)...”

Gogokoenen artean sartu

Gorde:
8

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Argitaratua 2025
Beste egile batzuk: “...Alison M. Meynert (14956260)...”

Gogokoenen artean sartu

Gorde:
9

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Argitaratua 2025
Beste egile batzuk: “...Alison M. Meynert (14956260)...”

Gogokoenen artean sartu

Gorde:
10

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Argitaratua 2025
Beste egile batzuk: “...Alison M. Meynert (14956260)...”

Gogokoenen artean sartu

Gorde:

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma nork Nicholas T. Younger (14956251)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification nork Robert L. Hollis (15034814)

Bilaketa egiteko lanabesak: